GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PAK4 in complex with inhibitor CZH216

Analyse Crystal structure of PAK4 in complex with inhibitor CZH216 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5XVA
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase pak 4
EC
2.7.11.1
UniProt
O96013
Ligands
8FU
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase pak 4 (EC 2.7.11.1)protein29340% helix, 18% strandO96013

Ligands and binding sites

  • 8FU · [6-chloranyl-4-[(5-methyl-1H-pyrazol-3-yl) amino]quinazolin-2-yl]-[(3R)-3-methylpiperazin-1-yl]methanone · ligand · chains A
  • EOH · Ethanol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12950.690.84458FU, EOH
2660.360.7815empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 5XVA · Crystal Structure of PAK4 in complex with inhibitor CZH216 · the same entry in another collection · chain A against A, TM-score 1.00
  • O96013 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase pak 4 (O96013) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.